Location History:
- Oakland, CA (US) (1997 - 1998)
- Alameda, CA (US) (1996 - 1999)
Company Filing History:
Years Active: 1996-1999
Title: The Innovative Contributions of Daniel E. Levy
Introduction
Daniel E. Levy is a prominent inventor based in Alameda, CA (US), known for his significant contributions to the field of synthetic matrix metalloprotease inhibitors. With a total of 7 patents to his name, Levy has made strides in developing compounds that address various medical conditions.
Latest Patents
Among his latest patents is a process for preparing synthetic matrix metalloprotease inhibitors. These inhibitors are crucial for treating or preventing diseases caused by unwanted mammalian matrix metalloprotease activity. The diseases targeted by these inhibitors include skin disorders, keratoconus, restenosis, rheumatoid arthritis, wounds, cancer, angiogenesis, and shock. Another notable patent involves sialyl lewis-x mimetics containing naphthyl backbones. This patent describes compounds with selectin binding activity that maintain a three-dimensionally stable configuration for sialic acid and fucose, or their analogs, derivatives, or mimics. These compounds are designed to facilitate binding between these groups and the selecting, showcasing Levy's innovative approach to complex biochemical challenges.
Career Highlights
Throughout his career, Daniel E. Levy has worked with notable organizations such as Glycomed, Inc. and the University of Florida Research Foundation, Incorporated. His work in these institutions has allowed him to further his research and development in the field of biochemistry and pharmaceuticals.
Collaborations
Levy has collaborated with esteemed colleagues, including John H. Musser and Peng Cho Tang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Daniel E. Levy's innovative work in the field of synthetic matrix metalloprotease inhibitors and related compounds highlights his significant impact on medical research. His contributions continue to pave the way for advancements in treatments for various diseases.